​
Login / Signup
Xingyu Zhou
ORCID
Publication Activity (10 Years)
Years Active: 2024-2024
Publications (10 Years): 4
Top Topics
Cancer Therapy
Prognostic Factors
Rheumatoid Arthritis Patients
Ejection Fraction
Top Venues
Expert opinion on investigational drugs
</>
This page only lists publications with an associated author ORCID identifier.
Publications
</>
Xingyu Zhou
,
Dong Xu
,
Meng Tao Li
,
Xiao-Feng Zeng
New investigational drugs to treat Sjogren's syndrome: lessons learnt from immunology.
Expert opinion on investigational drugs
33 (2) (2024)
Xingyu Zhou
,
Dong Xu
,
Meng Tao Li
,
Xiao-Feng Zeng
New investigational drugs to treat Sjogren's syndrome: lessons learnt from immunology.
Expert opinion on investigational drugs
(2024)
Xingyu Zhou
,
Dong Xu
,
Meng Tao Li
,
Xiao-Feng Zeng
New investigational drugs to treat Sjogren's syndrome: lessons learnt from immunology.
Expert opinion on investigational drugs
33 (2) (2024)
Xingyu Zhou
,
Dong Xu
,
Meng Tao Li
,
Xiao-Feng Zeng
New investigational drugs to treat Sjogren's syndrome: lessons learnt from immunology.
Expert opinion on investigational drugs
(2024)